Transaction Attraction: Trends, Opportunities, and Challenges in Oncology Partnerships

Ah, the elusive partnership – everyone wants one, but how do you get one? And on the flip slide, there are more oncology collaborations than ever, with even higher values – partnership values have grown 16% year-over-year.

The global cancer immunotherapy market is projected to more than double from $58.1 billion in 2018 to $126.9 billion by 2026. ^[1] It’s clear that oncology partnerships are lucrative, but how many T-cell therapies can the market hold? How much are companies actually paying for assets and targets?